Drug-resistant infections are on the rise, with a particular spike in carbapenemase-producing organisms (CPOs), as noted in a recent CDC report. Teresa Austin Karre, a microbiology expert at the University of Nebraska Medical Center, emphasizes the necessity for enhanced laboratory practices to identify these pathogens and their resistance mechanisms. With new strains like New Delhi metallo-β-lactamase (NDM) outpacing Klebsiella pneumoniae carbapenemase (KPC), laboratories must utilize appropriate technologies and collaborate closely with infection control teams to ensure effective surveillance and treatment.
Newsletters
Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.